TrialArthritis research & therapy2019

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study.

Jürgen Wollenhaupt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.